Episode Details
Back to Episodes
Rising Amid Flurry of CAR T Deals, Stylus Proves Cell Therapy Is Not Dead
Published 4 months ago
Description
Stylus Medicine CEO Emile Nuwaysir and Chief Scientific Officer Jason Fontenot speak with BioSpace about the biotech's work on next-generation genetic medicines—and why they think it’s the perfect time to be in the cell therapy game.
Stylus Medicine is featured in BioSpace's list, the top startups to watch in the U.S.
Host
Annalee Armstrong, Senior Editor, BioSpace
Guests
Emile Nuwaysir, CEO, Stylus Medicine
Jason Fontenot, Chief Scientific Officer, Stylus Medicine
Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.